British clinic is allowed to deny medicine; decision on cost has broad impact.
Lyall
Sarah
S
D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016527:Drug Costs; D015507:Drugs, Investigational; D005260:Female; D005380:Financing, Government; D015276:Health Care Rationing / Q000331:legislation & jurisprudence; D006801:Humans; D013222:State Medicine; D000068878:Trastuzumab; D006113:United Kingdom; D028761:Withholding Treatment / Q000331:legislation & jurisprudence*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D000068878:Trastuzumab